Medical Patients Clinical Trial
Official title:
My Health - My Medication. A Controlled Investigation of Patient Involvement in Administration of Medication in Hospitalized Medical Patients
The primary purpose of this study is to investigate if patient involvement in the medication
procedures through elements of the medication system One-Stop Dispensing (use of own
medication, placed in bedside locker, partly or self-administration of medication) and
focused dialogue about medication can maintain or improve the patients' health literacy to
perform the prescribed medical treatment during and after hospitalization.
The hypothesis is, that involving the patient in the medication procedure and focused
dialogue about the medicine during hospitalization will improve the patients' health
literacy measured by patient adherence, patient knowledge and perceptions of safety about
the medication. It is further expected that more time will be spent together with the
patient, and that the new medication procedures will be cost-neutral.
More people live with chronic diseases and therefore it is important for the healthcare
system to develop and organize initiatives that involve patients in their treatment.
In Denmark dispensing and administration of medication during hospitalization is a process
where the health staff has completely taken the responsibility from the patient, leaving
unused resources among patients and their relatives.
In general non-adherence to medication in patients with chronic medical diseases is a common
problem, which contributes to adverse health outcomes, increase healthcare expenditures and
reduce quality of life.
One-Stop Dispensing (use of own medication, placed in bedside locker, partly or
self-administration of medication during hospitalization), which is a medication system
developed in United Kingdom in the 1990s, could be an important part of a shift in the
healthcare system toward increasing patient involvement. Use of own medication and
self-administration aims, among other things, to increase adherence and the patient's
knowledge and understanding of their medication. One-Stop Dispensing has so far only been
tested on elective surgical patients in Denmark, which is why this study set out to
investigate acute hospitalized medical patients.
To investigate the effect of the medication system One-Stop Dispensing in Danish medical
patients the investigators planned a study including two designs. An observational before
and after implementing One-Stop Dispensing study and a randomized controlled study for the
intervention period.
Enrolment for an observational part of the study will begin in April 2016 with data
collection on patients under the traditional medication system.
In October 2016 enrolment will then begin for the intervention period including
randomization to a basic intervention including the elements of One-Stop Dispensing or an
extended intervention which besides One-Stop Dispensing also include a dialogue with the
patients about their medication during the hospitalization and at discharge. The data
collection will end in March 2017.
The research team will identify and verify patient eligibility. All participants will need
to provide informed written consent. For recruitment and informed consent, project
information will be discussed with the participants.
Baseline variables will be collected at admission and in the intervention period prior to
randomization. This includes questionnaire and baseline characteristics such as age, sex and
diagnosis. The primary measure is adherence measured at baseline and 1 month after
discharge. Knowledge of the patients' own medication will assessed by a health professional
also at baseline and again at discharge.
The study will end after one month follow up is completed for all the included patients.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04120740 -
Validation of Two Acitivity Monitors in Three Inpatient Populations.
|
||
| Terminated |
NCT00927602 -
Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
|
Phase 4 |